Patent Application
Utility
App. No. 18/935,127
· Confirmation No. 5883
ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME
Inventors:
Kunwar SHAILUBHAI, Stephen COMISKEY, Rong FENG, Juncai BAI, Ruoping ZHANG, Jun JIA, Junfeng ZHOU, Qiao ZHAO, Guoqing ZHANG
Applicant:
Bausch Health Ireland Limited
Non Final Action Mailed
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2026-08-13 | CTNF |
Non-Final Rejection | 10 | View | |
| 2026-08-13 | 892 |
List of references cited by examiner | 1 | View | |
| 2026-08-13 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2026-08-13 | FOR |
Foreign Reference | 125 | View | |
| 2026-08-13 | BIB |
Bibliographic Data Sheet | 2 | View | |
| 2026-08-13 | 1449 |
List of References cited by applicant and considered by examiner | 8 | View | |
| 2026-08-13 | SRNT |
Examiner's search strategy and results | 8 | View | |
| 2026-08-13 | 1449 |
List of References cited by applicant and considered by examiner | 12 | View | |
| 2025-05-29 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2025-02-21 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2025-02-21 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2025-02-21 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2025-02-20 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2025-02-13 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | — | View | |
| 2025-02-13 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2025-02-13 | SPEC |
Specification | 1 | View | |
| 2025-02-13 | CLM |
Claims | 2 | View | |
| 2025-02-13 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2025-02-13 | XT/ |
Extension of Time | 2 | View | |
| 2025-02-13 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-02-13 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-01-31 | FOR |
Foreign Reference | 86 | View | |
| 2025-01-31 | FOR |
Foreign Reference | 139 | View | |
| 2025-01-31 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 8 | View | |
| 2025-01-31 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-01-31 | FOR |
Foreign Reference | 125 | View | |
| 2025-01-31 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2025-01-31 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2025-01-31 | IDS.SIZEFEE |
Assertion regarding Information Disclosure Statement (IDS) Size Fee (SB/08C) | 1 | View | |
| 2025-01-31 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 12 | View | |
| 2024-11-15 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2024-11-15 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2024-11-15 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-11-15 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2024-11-15 | WELCOME.LET |
Welcome Letter from USPTO Director and Deputy Director | 1 | View | |
| 2024-11-04 | CRFE |
Sequence Listing in Computer Readable Format, No errors found | — | View | |
| 2024-11-04 | CRFE |
Sequence Listing in Computer Readable Format, No errors found | 14 | View | |
| 2024-11-01 | APP.TEXT |
Application body structured text document | — | View | |
| 2024-11-01 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2024-11-01 | DRW.NONBW |
Drawings-other than black and white line drawings | 16 | View | |
| 2024-11-01 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2024-11-01 | R3.73 |
Assignee showing of ownership per 37 CFR 3.73 | 3 | View | |
| 2024-11-01 | PA.. |
Power of Attorney | 1 | View | |
| 2024-11-01 | ADS |
Application Data Sheet | 12 | View | |
| 2024-11-01 | TRNA |
Transmittal of New Application | 2 | View | |
| 2024-11-01 | SPEC |
Specification | 120 | View | |
| 2024-11-01 | CLM |
Claims | 4 | View | |
| 2024-11-01 | ABST |
Abstract | 1 | View | |
| 2024-11-01 | OATH |
Oath or Declaration filed | 9 | View | |
| 2024-11-01 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2024-11-01 | SEQ.XML |
Sequence Listing (XML File) | 1 | View | |
| 2024-11-01 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2024-11-01 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View |
Inventors
Kunwar SHAILUBHAI
Audubon, PA
Stephen COMISKEY
Doylestown, PA
Rong FENG
Langhorne, PA
Juncai BAI
North Augusta, SC
Ruoping ZHANG
North Augusta, SC
Jun JIA
Shanghai, CHINA
Junfeng ZHOU
Shanghai, CHINA
Qiao ZHAO
Shanghai, CHINA
Guoqing ZHANG
Shanghai, CHINA
Attorneys & Agents of Record
Classification
USPC
428/402
C07K7/08
A61K38/10
B01D15/424
C07K1/14
C12N9/88
C12Y406/01002
Prosecution
- Examiner
- PATEL, RONAK C
- Art Unit
- 1658
- Customer No.
- 162421
- Docket No.
- 376464-2011US9 (00361)
- Confirmation No.
- 5883
Publication
- Pub. No.
- US20250171497A1
- Pub. Date
- 2025-05-29
Parent
is a Continuation of
→
App. 18/511,852
· US 12,146,003
Filed 2023-11-16
· Patented Case
Parent
is a Continuation of
→
App. 18/193,144
· US 11,834,521
Filed 2023-03-30
· Patented Case
Parent
is a Continuation of
→
App. 17/397,796
Filed 2021-08-09
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 17/207,215
Filed 2021-03-19
· Expressly Abandoned -- During Publication Process
Parent
is a Continuation of
→
App. 16/921,450
· US 11,142,549
Filed 2020-07-06
· Patented Case
Parent
is a Continuation of
→
App. 16/000,251
· US 10,745,441
Filed 2018-06-05
· Patented Case
Parent
is a Continuation of
→
App. 14/896,019
· US 10,011,637
Filed 2015-12-04
· Patented Case
Parent
PCT
is a National Stage Entry of
→
PCT/US2014/041143
Filed 2014-06-05
· Non Final Action Mailed
Parent
Claims priority from a provisional application
→
App. 61/831,402
Filed 2013-06-05
· Provisional Application Expired
U.S. PATENT SECURITY AGREEMENT
Recorded 2025-11-25
SECURITY INTEREST
Recorded 2025-10-07
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2025-03-26
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2025-03-26
SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2025-03-26
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/935,127
- Filed
- 2024-11-01
- Pub. No.
- US20250171497A1
- Examiner
- PATEL, RONAK C
- Art Unit
- 1658
External Links